| CTRI Number |
CTRI/2024/02/062284 [Registered on: 05/02/2024] Trial Registered Prospectively |
| Last Modified On: |
26/01/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Assessment of role of serum chloride levels in heart failure patients |
|
Scientific Title of Study
|
Hypochloremia as a predictor of In Hospital Outcome in Patients with Acute Decompensated Heart Failure |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Mujahed Ahmed |
| Designation |
Junior Resident , Department of General Medicine |
| Affiliation |
Kasturba medical college, Manipal |
| Address |
Department of General Medicine, Second floor, OPD
block Kasturba medical college, Manipal
Udupi KARNATAKA 576104 India |
| Phone |
9900269546 |
| Fax |
|
| Email |
mujahed.ahmed44@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Mukhyaprana Prabhu |
| Designation |
Professor |
| Affiliation |
Kasturba medical college, Manipal |
| Address |
Department of General Medicine, Second floor, OPD
block Kasturba medical college, Manipal
Udupi KARNATAKA 576104 India |
| Phone |
9449592986 |
| Fax |
|
| Email |
mm.prabhu@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Rakesh Noubade |
| Designation |
Senior Resident |
| Affiliation |
Kasturba medical college, Manipal |
| Address |
Department of General Medicine, Second floor, OPD
block Kasturba medical college, Manipal
Udupi KARNATAKA 576104 India |
| Phone |
8310090260 |
| Fax |
|
| Email |
rakesh.noubade@manipal.edu |
|
|
Source of Monetary or Material Support
|
| Kasturba medical college, manipal |
|
|
Primary Sponsor
|
| Name |
Dr Mujahed Ahmed |
| Address |
Department of General Medicine, Second floor, OPD
block Kasturba medical college, Manipal
Udupi
Karnataka
India |
| Type of Sponsor |
Other [SELF] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mujahed Ahmed |
Kasturba medical college, Manipal |
Department of General Medicine, Second floor, OPD
block
Udupi, 576104
Karnataka
India Udupi KARNATAKA |
9900269546
mujahed.ahmed44@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Kasturba Medical College and Kasturba Hospital I Institutional Ethics Committee 2 |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I50||Heart failure, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Patients admitted with diagnosis of acute decompensated heart failure will be included in the study |
|
| ExclusionCriteria |
| Details |
1)individuals less than 18 years
2)Pregnant women
3)Patients with acute Myocardial infarction
4)Patients with myocarditis
5)CKD patients
6)Patients in sepsis |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Correlation between admission chloride levels and duration of hospital stay in patients with acute decompensated heart failure |
At the time of recruitment |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NOT APPLICABLE |
NOT APPLICABLE |
|
|
Target Sample Size
|
Total Sample Size="106" Sample Size from India="106"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
08/02/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Heart failure (HF) is a major health problem in India with a post admission mortality of 20%–30%.[2 HF is one of the leading causes of hospitalization for patients aged 65 and above. Most of the literature in HF till recently has primarily focused on hyponatremia as the major predictor of short and long-term morbidity and mortality. Historically, sodium alone has been considered as the major contributor to volume homeostasis, and limited research attention has been given to chloride, a major extracellular anion that is abundantly present in intravascular and interstitial compartments and that counterbalances the positive charges of sodium. Several studies have found that the single best predictor of mortality was an elevated blood urea nitrogen (>43 mg/dl), followed by low systolic blood pressure (<115mm Hg) and high serum creatinine (>2.75mg/dl), additional factors being presence of congestion, reduced left ventricular ejection fraction (LVEF), ischemic etiology, anemia, elevated natriuretic peptide levels. Recent epidemiological studies have implicated chloride, rather than sodium, as the driver and predictor of poor survival previously attributed to hyponatremia in heart failure.
DESCRIPTION Patients with diagnosis of acute decompensated heart failure admitted in Kasturba Hospital, In Department of Medicine and Department Of Cardiology in Wards, HDUs,ICUs will be divided into tertiles based on admission chloride levels. ïµ The following details of all patients will be included in the study. ïµ Age, sex, demographic data and comorbidities. ïµ History with particular emphasis on treatment history and cardiac symptomatology before admission and through the course of hospital stay. ïµ Physical examination with focus on weight, jugular venous pressure (JVP), pedal edema, cardiac auscultation. ïµ Investigations to be done: echocardiography, Serum electrolytes, Serum uric acid, NT pro BNP, Renal Function Test (RFT), Liver Function Test (LFT), Complete Blood Count (CBC).
All the quantitative parameters such as age of patient and length of stay , serum chloride level,serum potassium, serum urea, serum creatinine, haemoglobin levels, ejection fraction( EF%) and serum sodium levels will be expressed as mean and standard deviation or median with interquartile range in case of non-normality of data. Categorical variables, such as gender, presence of diabetes mellitus, hypertension, smoking, etc. will be presented as percentages. The differences in the mean values of various parameters such as mean length of stay, blood urea nitrogen, serum potassium, sodium, uric acid, NT pro BNP, etc. amongst different serum chloride levels will be tested for statistical significance by analysis of variance or by non-parametric test of significance in case of non-normality of the data. The relationship between the length of stay and serum chloride levels will be assessed by estimating correlation coefficient. Multiple correlational coefficient will also be calculated to evaluate the relationship of serum chloride levels with length of stay considering the other confounding factors such as blood urea nitrogen, serum potassium, sodium, uric acid, NT pro BNP. Differences in mean or median values between the two groups such as serum chloride <96meq/L, >101 meq/L will be tested for statistical significance by Student –t test or Mann-Whitney test in case of non-normality of the data. Similarly, association of various qualitative variables such as presence of various comorbidities with different groups of serum chloride levels will be tested for statistical significance by Chi-Square test of significance.
|